Cipla informs about press release

12 Nov 2018 Evaluate

Cipla has informed about Press Release dated 12th November, 2018, titled ‘Cipla receives final approval for generic version of Roche’s Valcyte (Valganciclovir Tablets 450mg)’. 

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1466.15 5.55 (0.38%)
09-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.95
Dr. Reddys Lab 1209.45
Cipla 1466.15
Zydus Lifesciences 894.95
Lupin 2181.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×